ABAdam Berrington

Adam Berrington

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Adam Berrington has a total of 184 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurochemical Endpoints to Inform Early‐Stage Trials of Spinocerebellar Ataxia 2 and 3 in a Multisite Setting

    by James M. Joers, Yaqiao Wei, Dinesh K. Deelchand, Adam Berrington, Young Woo Park, Guita Banan, Michal Povazan, Jens T. Rosenberg, André J. W. van der Kouwe, Tetsuo Ashizawa, et al.

    Objective: Neurochemical levels measured by brain MR spectroscopy (MRS) have been proposed as endpoints for clinical trials in early‐stage spinocerebellar ataxia (SCA) trials. We tested their trial‐readiness by quantifying neurochemicals in three affected brain regions in early‐stage cohorts of SCA2 and SCA3, examining their reproducibility in both patients and controls in a multisite/multivendor setting, and determining if the same neurochemical outcomes can be used as endpoints for different SCA genotypes. Methods: Seventy‐two participants (18 SCA2, mean Scale for the Assessment and Rating of Ataxia (SARA) = 9 +/− 5; 25 SCA3, mean SARA = 10 +/− 6; 29 controls) underwent 3 T scans at four sites using scanners from two vendors and a harmonized MRS protocol. Scans were performed twice with a maximum 2‐week interval. We measured neurochemical concentrations in the cerebellum, pons, and putamen, and assessed their within‐ and between‐site reproducibility and associations with clinician‐ and patient‐reported outcomes. Results: Test–retest coefficients of variance were comparable across sites and vendors, but concentration estimates had to be adjusted for sites to account for small vendor‐based biases. Total N ‐acetylaspartate (tNAA) and glutamate were lower, and myo ‐inositol (mI) and total creatine (tCr) were higher in the cerebellum and pons in both SCAs vs. controls. Pontine tNAA and mI, and cerebellar tNAA, mI, and glutamate levels were significantly different between SCA2 and SCA3, with strong effect sizes (|Cohen's d | = 1.1–2.1). The tNAA/tCr ratio had the strongest associations with clinical outcomes (|r| ≥ 0.5), with stronger associations in the cerebellum for SCA2 and in the pons for SCA3. Interpretation: These data support the use of tNAA and its ratios in a genotype‐specific manner in early‐stage SCA2 and SCA3 trials in the multisite/multivendor setting.


  • Open Access

    Investigating neurometabolite changes in response to median nerve stimulation

    by Mairi S. Houlgreave, Katherine Dyke, Adam Berrington, Stephen R. Jackson

    Background Rhythmic median nerve stimulation (MNS) at 10Hz has been shown to cause a substantial reduction in tic frequency in individuals with Tourette Syndrome. The mechanism of action is currently unknown, but is hypothesised to involve entrainment of oscillations within the sensorimotor cortex. Objective We used functional magnetic resonance spectroscopy (fMRS) to explore the dynamic effects of MNS on neurometabolite concentrations. Methods Here, we investigated the effects of rhythmic and arrhythmic 10Hz MNS on glutamate (Glu) and GABA concentrations in the contralateral sensorimotor cortex in 15 healthy controls, using a blocked fMRS design. We used a Mescher-Garwood-semi-localised by adiabatic selective refocusing (MEGA-sLASER) sequence at 7T. Results Our results show no difference in the difference-from-baseline measures between the two stimulation conditions. Looking at the effect of MNS over both conditions there is a trend for an initial increase in Glu/tCr (total creatine) followed by a decrease over time, whereas GABA/tCr decreased during each stimulation block. Conclusion These results suggest that despite entrainment of oscillations during rhythmic MNS, there are no significant differences in the tonic neuromodulatory effects of rhythmic and arrhythmic stimulation. The reduction in glutamate over the course of stimulation may reflect a decrease in glutamatergic firing due to adaptation. This may make it less likely that an involuntary movement is generated during continuous stimulation.

  • Magnetic Resonance Spectroscopy: Clinical Applications

    by Alena Horská, Adam Berrington, Peter B. Barker, Ivan Tkáč


  • Open Access

    Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial

    by Stefan Pszczolkowski, William J Cottam, Paul M Briley, Sarina J Iwabuchi, Catherine Kaylor-Hughes, Abdulrhman Shalabi, Ben Babourina-Brooks, Adam Berrington, Shaun Barber, Ana Suazo Di Paola, et al.

    Background: Depression is a substantial health and economic burden. In approximately one-third of patients, depression is resistant to first-line treatment; therefore, it is essential to find alternative treatments. Transcranial magnetic stimulation (TMS) is a neuromodulatory treatment involving the application of magnetic pulses to the brain that is approved in the United Kingdom and the United States in treatment-resistant depression. This trial aims to compare the clinical effectiveness, cost-effectiveness, and mechanism of action of standard treatment repetitive TMS (rTMS) targeted at the F3 electroencephalogram site with a newer treatment—a type of TMS called theta burst stimulation (TBS) targeted based on measures of functional brain connectivity. This protocol outlines brain imaging acquisition and analysis for the Brain Imaging Guided Transcranial Magnetic Stimulation in Depression (BRIGhTMIND) study trial that is used to create personalized TMS targets and answer the proposed mechanistic hypotheses. Objective: The aims of the imaging arm of the BRIGhTMIND study are to identify functional and neurochemical brain signatures indexing the treatment mechanisms of rTMS and connectivity-guided intermittent theta burst TMS and to identify imaging-based markers predicting response to treatment. Methods: The study is a randomized double-blind controlled trial with 1:1 allocation to either 20 sessions of TBS or standard rTMS. Multimodal magnetic resonance imaging (MRI) is acquired for each participant at baseline (before TMS treatment) with T1-weighted and task-free functional MRI during rest used to estimate TMS targets. For participants enrolled in the mechanistic substudy, additional diffusion-weighted sequences are acquired at baseline and at posttreatment follow-up 16 weeks after treatment randomization. Core data sets of T1-weighted and task-free functional MRI during rest are acquired for all participants and are used to estimate TMS targets. Additional sequences of arterial spin labeling, magnetic resonance spectroscopy, and diffusion-weighted images are acquired depending on the recruitment site for mechanistic evaluation. Standard rTMS treatment is targeted at the F3 electrode site over the left dorsolateral prefrontal cortex, whereas TBS treatment is guided using the coordinate of peak effective connectivity from the right anterior insula to the left dorsolateral prefrontal cortex. Both treatment targets benefit from the level of MRI guidance, but only TBS is provided with precision targeting based on functional brain connectivity. Results: Recruitment began in January 2019 and is ongoing. Data collection is expected to continue until January 2023. Conclusions: This trial will determine the impact of precision MRI guidance on rTMS treatment and assess the neural mechanisms underlying this treatment in treatment-resistant depressed patients. Trial Registration: ISRCTN Registry ISRCTN19674644; https://www.isrctn.com/ISRCTN19674644 International Registered Report Identifier (IRRID): DERR1-10.2196/31925


  • Feasibility and Biological Activity of a Ketogenic/Intermittent-Fasting Diet in Patients With Glioma

    by Karisa C. Schreck, Fang-Chi Hsu, Adam Berrington, Bobbie Henry-Barron, Diane Vizthum, Lindsay Blair, Eric H. Kossoff, Linda Easter, Christopher T. Whitlow, Peter B. Barker, et al.

    Objective To examine the feasibility, safety, systemic biological activity, and cerebral activity of a ketogenic dietary intervention in patients with glioma. Methods Twenty-five patients with biopsy-confirmed World Health Organization grade 2 to 4 astrocytoma with stable disease after adjuvant chemotherapy were enrolled in an 8-week Glioma Atkins-Based Diet (GLAD). GLAD consisted of 2 fasting days (calories Rs = 0.52, p = 0.05). Subgroup analysis of isocitrate dehydrogenase–mutant glioma showed no differences in cerebral metabolites after controlling for ketonuria. Conclusion The GLAD dietary intervention, while demanding, produced meaningful ketonuria and significant systemic and cerebral metabolic changes in participants. Ketonuria in participants correlated with cerebral ketone concentration and appears to be a better indicator of systemic activity than patient-reported food records. Trial Registration Information ClinicalTrials.gov Identifier: NCT02286167.


  • Open Access

    Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2–Induced Changes for a Randomized Double-blind Controlled Trial (Preprint)

    by Stefan Pszczolkowski, William J Cottam, Paul M Briley, Sarina J Iwabuchi, Catherine Kaylor-Hughes, Abdulrhman Shalabi, Ben Babourina-Brooks, Adam Berrington, Shaun Barber, Ana Suazo Di Paola, et al.

    BACKGROUND Depression is a substantial health and economic burden. In approximately one-third of patients, depression is resistant to first-line treatment; therefore, it is essential to find alternative treatments. Transcranial magnetic stimulation (TMS) is a neuromodulatory treatment involving the application of magnetic pulses to the brain that is approved in the United Kingdom and the United States in treatment-resistant depression. This trial aims to compare the clinical effectiveness, cost-effectiveness, and mechanism of action of standard treatment repetitive TMS (rTMS) targeted at the F3 electroencephalogram site with a newer treatment—a type of TMS called theta burst stimulation (TBS) targeted based on measures of functional brain connectivity. This protocol outlines brain imaging acquisition and analysis for the Brain Imaging Guided Transcranial Magnetic Stimulation in Depression (BRIGhTMIND) study trial that is used to create personalized TMS targets and answer the proposed mechanistic hypotheses. OBJECTIVE The aims of the imaging arm of the BRIGhTMIND study are to identify functional and neurochemical brain signatures indexing the treatment mechanisms of rTMS and connectivity-guided intermittent theta burst TMS and to identify imaging-based markers predicting response to treatment. METHODS The study is a randomized double-blind controlled trial with 1:1 allocation to either 20 sessions of TBS or standard rTMS. Multimodal magnetic resonance imaging (MRI) is acquired for each participant at baseline (before TMS treatment) with T1-weighted and task-free functional MRI during rest used to estimate TMS targets. For participants enrolled in the mechanistic substudy, additional diffusion-weighted sequences are acquired at baseline and at posttreatment follow-up 16 weeks after treatment randomization. Core data sets of T1-weighted and task-free functional MRI during rest are acquired for all participants and are used to estimate TMS targets. Additional sequences of arterial spin labeling, magnetic resonance spectroscopy, and diffusion-weighted images are acquired depending on the recruitment site for mechanistic evaluation. Standard rTMS treatment is targeted at the F3 electrode site over the left dorsolateral prefrontal cortex, whereas TBS treatment is guided using the coordinate of peak effective connectivity from the right anterior insula to the left dorsolateral prefrontal cortex. Both treatment targets benefit from the level of MRI guidance, but only TBS is provided with precision targeting based on functional brain connectivity. RESULTS Recruitment began in January 2019 and is ongoing. Data collection is expected to continue until January 2023. CONCLUSIONS This trial will determine the impact of precision MRI guidance on rTMS treatment and assess the neural mechanisms underlying this treatment in treatment-resistant depressed patients. CLINICALTRIAL ISRCTN Registry ISRCTN19674644; https://www.isrctn.com/ISRCTN19674644 INTERNATIONAL REGISTERED REPORT DERR1-10.2196/31925

  • Open Access

    Estimation and removal of spurious echo artifacts in single‐voxel MRS using sensitivity encoding

    by Adam Berrington, Michal Považan, Peter B. Barker

    Purpose: In localized MRS, spurious echo artifacts commonly occur when unsuppressed signal outside the volume of interest is excited and refocused. In the spectral domain, these signals often overlap with metabolite resonances and hinder accurate quantification. Because the artifacts originate from regions separate from the target MRS voxel, this work proposes that sensitivity encoding based on receive‐coil sensitivity profiles may be used to separate these signal contributions.Methods: Numerical simulations were performed to explore the effect of sensitivity‐encoded separation for unknown artifact regions. An imaging‐based approach was developed to identify regions that may contribute to spurious echo artifacts, and tested for sensitivity‐based unfolding of signal on six data sets from three brain regions. Spectral data reconstructed using the proposed method (“ERASE”) were compared with the standard coil combination.Results: The method was able to fully unfold artifact signals if regions were known a priori. Mismatch between estimated and true artifact regions reduced the efficiency of removal, yet metabolite signals were unaffected. Water suppression imaging was able to identify regions of unsuppressed signal, and ERASE (from up to eight regions) led to visible removal of artifacts relative to standard reconstruction. Fitting errors across major metabolites were also lower; for example, Cramér–Rao lower bounds of myo‐inositol were 13.7% versus 17.5% for ERASE versus standard reconstruction, respectively.Conclusion: The ERASE reconstruction tool was demonstrated to reduce spurious echo artifacts in single‐voxel MRS. This tool may be incorporated into standard workflows to improve spectral quality when hardware limitations or other factors result in out‐of‐voxel signal contamination.


  • Open Access

    Calibration‐free regional RF shims for MRS

    by Adam Berrington, Michal Považan, Christopher Mirfin, Stephen Bawden, Young Woo Park, Daniel C. Marsh, Richard Bowtell, Penny A. Gowland

    Purpose: Achieving a desired RF transmit field () in small regions of interest is critical for single‐voxel MRS at ultrahigh field. Radio‐frequency (RF) shimming, using parallel transmission, requires mapping and optimization, which limits its ease of use. This work aimed to generate calibration‐free RF shims for predefined target regions of interest, which can be applied to any participant, to produce a desired absolute magnitude (||).Methods: The RF shims were found offline by joint optimization on a database comprising maps from 11 subjects, considering regions of interest in occipital cortex, hippocampus and posterior cingulate, as well as whole brain. The || achieved was compared with a tailored shimming approach, and MR spectra were acquired using tailored and calibration‐free shims in 4 participants. Global and local 10g specific‐absorption‐rate deposition were estimated using Duke and Ella dielectric models.Results: There was no difference in the mean || produced using calibration‐free versus tailored RF shimming in the occipital cortex (p = .15), hippocampus (p = .5), or posterior cingulate (p = .98), although differences were observed in the RMS error ||. Spectra acquired using calibration‐free shims had similar SNR and low residual water signal. Under identical power settings, specific‐absorption‐rate deposition was lower compared with operating in quadrature mode. For example, the total head specific absorption rate was around 35% less for the occipital cortex.Conclusion: This work demonstrates that static RF shims, optimized offline for small regions, avoid the need for mapping and optimization for each region of interest and participant. Furthermore, power settings may be increased when using calibration‐free shims, to better take advantage of RF shimming.


  • Open Access

    Estimation and Removal of spurious echo Artifacts in single-voxel MRS using Sensitivity Encoding

    by Adam Berrington, Michal Považan, Peter B Barker

    Purpose: In localized MR spectroscopy, spurious echo artifacts commonly occur when unsuppressed signal outside the volume-of-interest is exicted and refocused. In the spectral domain, these signals often overlap with metabolite resonances and hinder accurate quantification. Since the artifacts orginate from regions separate from the target MRS voxel, this work proposes that sensitivity encoding based on receive coil sensitivity profiles may be used to separate these signal contributions. Methods: Numerical simulations were performed to explore the effect of sensitivity encoded separation for unknown artifact regions. An imaging-based approach was developed to identify regions that may contribute to spurious echo artifacts, and tested for sensitivity-based unfolding of signal contribution on 6 datasets from 3 brain regions. Spectral data reconstructed using the proposed method (‘ERASE’) were compared to standard coil combination. Results: The method was able to fully separate metabolite and artifact signals if regions were known a priori . Mismatch between estimated and actual artifact locations reduced the efficiency of artifact removal. Water suppression imaging (WSI) was able to identify unsuppressed signal remote from the MRS voxel in all cases, and ERASE reconstruction (of up to 8 distinct locations) led to improvements in spectral quality and reduced fitting errors for the major metabolites compared to standard reconstruction, without significant degradation of spectral SNR. Conclusion: The ERASE reconstruction tool was demonstrated to reduce spurious echo artifacts in single voxel MRS. ERASE may be incorporated into standard MRS workflows to improve spectral quality when scanner hardware limitations or other factors result in out-of-voxel signal contamination.


  • Open Access

    Calibration-free regional RF shims for MR spectroscopy

    by Adam Berrington, Michal Považan, Christopher Mirfin, Stephen Bawden, Young Woo Park, Daniel C. Marsh, Richard Bowtell, Penny Gowland

    Purpose: Sufficient control of the RF transmit field (B 1 + ) in small regions-of-interest (ROIs) is critical for single voxel MR spectroscopy at ultra-high field. Static RF shimming, using parallel transmit (pTx), can improve B 1 + , but must be calibrated for each participant and ROI, which limits its applicability. Additionally, specific-absorption-rate (SAR) becomes hard to predict. This work aimed to find RF shims, which can be applied to any participant, to produce the desired |B 1 + | within pre-defined target ROIs. Methods: RF shims were found offline by joint-optimisation on a database, comprising B 1 + maps from 11 subjects, considering ROIs in occipital cortex, hippocampus and posterior-cingulate, as well as the whole brain. The B 1 + magnitude achieved using calibration-free RF shims was compared to a tailored shimming approach, and MR spectra were acquired using tailored and calibration-free RF shimming in 4 participants. Global and local 10g SAR deposition were modelled. Results: Calibration-free RF shims resulted in similar |B 1 + | in small ROIs compared to tailored shimming, in addition to producing spectra of excellent quality and equivalent SNR. Only a small database size was required. SAR deposition was reduced compared to operating in quadrature mode for all ROIs. Conclusion: This work demonstrates that static RF shims, optimised offline for small regions in single voxel MRS, avoid the need for lengthy B 1 + mapping and pTx optimisation for each ROI and participant. Furthermore, power settings may be increased when using calibration-free shims to better take advantage of the flexibility provided by RF shimming for regional acquisition at ultra-high field.